Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001181431-14-036913)

Filing Details

Accession Number:: 0001181431-14-036913
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2014-11-20 09:16:11
Reporting Period:: 2014-11-18

Filing Date:: 2014-11-20
Accepted Time:: 2014-11-20 09:16:11
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1382911	Orexigen Therapeutics Inc.	OREX	Pharmaceutical Preparations (2834)	651178822

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1279735	C Louis Bock	C/O Orexigen Therapeutics, Inc. 3344 N. Torrey Pines Court, Suite 200 La Jolla CA 92037		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2014-11-18	625	$5.58	27,677	No	4	P	Direct
Common Stock	Acquisiton	2014-11-18	700	$5.58	700	No	4	P	Indirect	By Spouse

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Indirect	By Spouse

Footnotes

Shares purchased by the Reporting Person through an IRA Contributory Account.
Shares purchased by, and for the benefit of, the Spouse of the Reporting Person through an IRA Contributory Account managed by the Reporting Person. The Reporting Person disclaims beneficial ownership of these shares, and this report shall not be deemed an admission that the Reporting Person owns the shares for the purposes of Section 16 or any other purpose.